A detailed history of Magnetar Financial LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Magnetar Financial LLC holds 482,340 shares of JNJ stock, worth $73.9 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares
482,340
Previous 552,484 12.7%
Holding current value
$73.9 Million
Previous $80.8 Million 3.2%
% of portfolio
2.27%
Previous 2.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $10.2 Million - $11.7 Million
-70,144 Reduced 12.7%
482,340 $78.2 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $79.8 Million - $87.2 Million
552,484 New
552,484 $80.8 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $3.25 Million - $3.88 Million
21,515 New
21,515 $3.33 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $3.77 Million - $4.19 Million
-23,359 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $112,592 - $120,775
-706 Reduced 2.93%
23,359 $3.85 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $3.68 Million - $4.1 Million
24,065 New
24,065 $3.96 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $936,053 - $1.03 Million
-6,668 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $858,905 - $1.04 Million
6,668 New
6,668 $938,000
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $196,518 - $220,032
-1,548 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $584,929 - $643,310
-4,460 Reduced 74.23%
1,548 $216,000
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $368,707 - $406,874
3,088 Added 105.75%
6,008 $729,000
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $888,960 - $1.05 Million
-7,106 Reduced 70.88%
2,920 $374,000
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $452,446 - $495,201
-3,448 Reduced 25.59%
10,026 $1.4 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $1.74 Million - $1.82 Million
13,474
13,474 $1.75 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.